Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans.
Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans.
A number of studies have been performed examining the influence of various probiotic organisms, either alone or in combination, on immune parameters, infectious outcomes, and inflammatory conditions in humans. Some components of the immune response, including phagocytosis, natural killer cell activity and mucosal immunoglobulin A production (especially in children), can be improved by some probiotic bacteria. Other components, including lymphocyte proliferation, the production of cytokines and of antibodies other than immunoglobulin A appear less sensitive to probiotics. Probiotics, including lactobacilli and bifidobacteria, administered to children can reduce incidence and duration of diarrhoea, but the precise effects depend upon the nature of the condition. Probiotic supplementation can reduce the risk of travellers' diarrhoea in adults, but does not affect duration. The effect of probiotics on other infectious outcomes is less clear. Probiotics may benefit children and adults with irritable bowel syndrome and adults with ulcerative colitis; studies in Crohn's Disease are less clear. Probiotics have little effect in rheumatoid arthritis. Probiotic supplementation, especially with lactobacilli and bifidobacteria, can reduce risk and severity of allergic disease, particular atopic dermatitis; early supplementation appears to be effective. Overall, the picture that emerges from studies of probiotics on immune, infectious and inflammatory outcomes in humans is mixed and there appear to be large species and strain differences in effects seen. Other reasons for differences in effects seen will include dose of probiotic organism used, duration of supplementation, characteristics of the subjects studied, sample size, and technical differences in how the measurements were made
lymphocyte, macrophage, NK cell, antibody, cytokine
1428-1518
Lomax, A.R.
8a11f54e-999d-4442-b1e4-047d3006add1
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
1 May 2009
Lomax, A.R.
8a11f54e-999d-4442-b1e4-047d3006add1
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Lomax, A.R. and Calder, P.C.
(2009)
Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans.
Current Pharmaceutical Design, 15 (13), .
(doi:10.2174/138161209788168155).
Abstract
A number of studies have been performed examining the influence of various probiotic organisms, either alone or in combination, on immune parameters, infectious outcomes, and inflammatory conditions in humans. Some components of the immune response, including phagocytosis, natural killer cell activity and mucosal immunoglobulin A production (especially in children), can be improved by some probiotic bacteria. Other components, including lymphocyte proliferation, the production of cytokines and of antibodies other than immunoglobulin A appear less sensitive to probiotics. Probiotics, including lactobacilli and bifidobacteria, administered to children can reduce incidence and duration of diarrhoea, but the precise effects depend upon the nature of the condition. Probiotic supplementation can reduce the risk of travellers' diarrhoea in adults, but does not affect duration. The effect of probiotics on other infectious outcomes is less clear. Probiotics may benefit children and adults with irritable bowel syndrome and adults with ulcerative colitis; studies in Crohn's Disease are less clear. Probiotics have little effect in rheumatoid arthritis. Probiotic supplementation, especially with lactobacilli and bifidobacteria, can reduce risk and severity of allergic disease, particular atopic dermatitis; early supplementation appears to be effective. Overall, the picture that emerges from studies of probiotics on immune, infectious and inflammatory outcomes in humans is mixed and there appear to be large species and strain differences in effects seen. Other reasons for differences in effects seen will include dose of probiotic organism used, duration of supplementation, characteristics of the subjects studied, sample size, and technical differences in how the measurements were made
This record has no associated files available for download.
More information
Published date: 1 May 2009
Keywords:
lymphocyte, macrophage, NK cell, antibody, cytokine
Identifiers
Local EPrints ID: 147693
URI: http://eprints.soton.ac.uk/id/eprint/147693
PURE UUID: 13feb951-6de1-4286-b465-461d23b39e68
Catalogue record
Date deposited: 26 Apr 2010 11:56
Last modified: 14 Mar 2024 02:39
Export record
Altmetrics
Contributors
Author:
A.R. Lomax
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics